{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:10:36Z","timestamp":1791900636438,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2004,9,25]],"date-time":"2004-09-25T00:00:00Z","timestamp":1096070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Springer Semin Immun"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s00281-004-0166-2","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T07:44:32Z","timestamp":1096011872000},"page":"119-132","source":"Crossref","is-referenced-by-count":136,"title":["Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases"],"prefix":"10.1007","volume":"26","author":[{"given":"William","family":"Krivit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,25]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","unstructured":"Aubourg P, Blanche S, Jambaque I, et al (1990) Reversal of early neurological and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322:1860","DOI":"10.1056\/NEJM199006283222607"},{"key":"CR2","doi-asserted-by":"crossref","unstructured":"Baker RH, Trautman JC, Zimmerman D (1990) Late juvenile onset Krabbe?s disease. Ophthalmology 97:1176","DOI":"10.1016\/S0161-6420(90)32439-9"},{"key":"CR3","unstructured":"Bayever E, August CS, Kamani N, et al (1992) Allogeneic bone marrow transplanatation for Nieman-Pick Disease (Type IA). Bone Marrow Transplant 10 (Suppl 1):85"},{"key":"CR4","doi-asserted-by":"crossref","unstructured":"Bezman I, Moser AB, Raymond GV, et al (2001) Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 29:512","DOI":"10.1002\/ana.101"},{"key":"CR5","doi-asserted-by":"crossref","unstructured":"Biswas S, Levine SM (2002) Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy. Pediatr Res 51:40","DOI":"10.1203\/00006450-200201000-00009"},{"key":"CR6","doi-asserted-by":"crossref","unstructured":"Braunlin EA, Hopwood JJ, Krivit W, et al (2001) Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in Hurler (MPS I-H). Am J Cardiol 88:1075","DOI":"10.1016\/S0002-9149(01)01999-3"},{"key":"CR7","doi-asserted-by":"crossref","unstructured":"Braunlin EA, Hopwood JJ, Krivit W, et al (2003) Usefulness of bone marrow transplantation in the Hurler syndrome. Am J Cardiol 93:882","DOI":"10.1016\/S0002-9149(03)00909-3"},{"key":"CR8","doi-asserted-by":"crossref","unstructured":"Cox TM, Lachmann R, Hollak C, et al (2000) Novel oral treatment of Gaucher?s disease with N-butyldeoxynojiumycin (OCT 918) to decrease substrate biosynthesis. Lancet 355:1401","DOI":"10.1016\/S0140-6736(00)02161-9"},{"key":"CR9","unstructured":"DeGasperi R, Krivit W, Kolodny EH, et al (1996) Molecular heterogeneity of late-onset form of globoid cell leukodystrophy. Am J Hum Genet 59:1233"},{"key":"CR10","doi-asserted-by":"crossref","unstructured":"De Gasperi R, Raghavan SS, Krivit W, et al (2000) Measurements from normal umbilical cord blood of four lysosomal enzymatic activities: alpha-l-iduronidase (Hurler), galactocerebrosidase (globoid cell leukodsytrophy), arylsulfatase A (metachromatic leukodystrophy). Bone Marrow Transplant 25:541","DOI":"10.1038\/sj.bmt.1702185"},{"key":"CR11","doi-asserted-by":"crossref","unstructured":"Ezoe T, Vanier M, Suzuki K, et al (2000) Twitcher mice with only a single active galactosylceramide synthase gene exhibit clearly detectable but therapeutically minor phenotype improvements. J Neurosci Res 59:179","DOI":"10.1002\/(SICI)1097-4547(20000115)59:2<179::AID-JNR4>3.0.CO;2-N"},{"key":"CR12","doi-asserted-by":"crossref","unstructured":"Gasper PW, Thrall MA, Wenger DA, et al 1984) Correction of feline arylsulfatase B deficiency (MPS VI) by bone marrow transplantation. Nature 311:467","DOI":"10.1038\/312467a0"},{"key":"CR13","doi-asserted-by":"crossref","unstructured":"Grewal SS, Shapiro EG, Krivit W, et al (2004) Effective treatment of ?-mannosidosis by allogeneic stem cell transplantation. J Pediatr 144:569?573","DOI":"10.1016\/j.jpeds.2004.01.025"},{"key":"CR14","doi-asserted-by":"crossref","unstructured":"Guffon N, Souillet G, Maire I, et al (1999) Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 133:119","DOI":"10.1016\/S0022-3476(98)70201-X"},{"key":"CR15","doi-asserted-by":"crossref","unstructured":"Guo AC, Petrella JR, Kurtzberg J, et al (2001) Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging. Initial experience. Radiology 215:809","DOI":"10.1148\/radiology.218.3.r01mr14809"},{"key":"CR16","doi-asserted-by":"crossref","unstructured":"Hite S, Peters C, Krivit W (2000) Correction of odontoid dysplasia following bone marrow transplantation and engraftment in Hurler syndrome(MPSI-H). Pediatr Radiol 30:464","DOI":"10.1007\/s002470000210"},{"key":"CR17","doi-asserted-by":"crossref","unstructured":"Jacobson P, Prak JJ, Defor TE, et al (2001) Oral busulfan pharmacokinetics and engraftment in childen with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 27:855","DOI":"10.1038\/sj.bmt.1703010"},{"key":"CR18","doi-asserted-by":"crossref","unstructured":"Keeling KM, Brooks DA, Hopwood JJ (2001) Gentamycin-mediated suppression of Hurler syndrome stop mutations restores a low level of ?-l-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum Mol Genet 10:201","DOI":"10.1093\/hmg\/10.3.291"},{"key":"CR19","doi-asserted-by":"crossref","unstructured":"Keene CD, Rodrigues, CM, Steer CJ, et al (2002) Taurodesoxycholiic acid, a bile acid, is neuroprotective in a transgeneic animal model of Huntingtons?s disease. Proc Natl Acad Sci USA 99:10671","DOI":"10.1073\/pnas.162362299"},{"key":"CR20","unstructured":"Krivit W (2002) Stem cell bone marrow transplantation in patients with metabolic storage diseases. Adv Pediatr 49:359"},{"key":"CR21","unstructured":"Krivit W (2004) Metachromatic Leukodystrophy. In: Zimran E (ed) Glycolipid storage diseases. Adis International, Oxford 9:91?100"},{"key":"CR22","doi-asserted-by":"crossref","unstructured":"Krivit W, Pierpont ME, Ayaz K, et al (1984) Bone marrow transplantation in the Maroteaux-Lamy syndrome(MPS VI). Biochemical and clinical status 24 months after transplantation. N Engl J Med 311:1606","DOI":"10.1056\/NEJM198412203112504"},{"key":"CR23","unstructured":"Krivit W, Freese D, Chan KW, Kulkarni R (1992) Wolman?s disease: a review of treatment with bone marrow transplantation and considerations for the future. Bone Marrow Transplant 10 (Suppl 1):97"},{"key":"CR24","doi-asserted-by":"crossref","unstructured":"Krivit W, Shapiro EG, Peters C, et al (1998) Hematopoietic stem cell transplantation in globoid cell leukodystrophy: N Engl J Med 338:1119","DOI":"10.1056\/NEJM199804163381605"},{"key":"CR25","doi-asserted-by":"crossref","unstructured":"Krivit W, Peters C, Dusenbery K, et al (2000) Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant 26:567","DOI":"10.1038\/sj.bmt.1702557"},{"key":"CR26","unstructured":"Krivit W, Kurtzberg J, Kolodny EH, et al (2004) Globoid cell leukodystrophy (Krabbe disease): study of normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations. In: Abstracts of American Neurochemicl Socity Meeting, New York, 18 August"},{"key":"CR27","unstructured":"Krivit W, Kurtzberg J, et al (2004) Proof of Principle: globoid cell leukodystrophy late-onset: effective therapeutic intervention in disease course by use of hematopoietic stem cell transplantation. In: Abstracts of the 149 Annual Meeting of Pediatric Academic Societies, San Francisco, 2 May 2004"},{"key":"CR28","doi-asserted-by":"crossref","unstructured":"Lachman RH, Platt FM (2001) Substrate reduction therapy for sphingolipid storage disorders. Expert Opin Investig Drugs10:455","DOI":"10.1517\/13543784.10.3.455"},{"key":"CR29","doi-asserted-by":"crossref","unstructured":"Liu Y, Wada R, Kawa H (1999) A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 102:497","DOI":"10.1172\/JCI5542"},{"key":"CR30","doi-asserted-by":"crossref","unstructured":"Li Y, Brockman K, Scott CR, et al (2004) Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease. Clin Chem 50:638","DOI":"10.1373\/clinchem.2003.028381"},{"key":"CR31","doi-asserted-by":"crossref","unstructured":"Maria BJ, Moser H, Naidu S, et al (2003 ) Leukodystrophies, pathogenesis, diagnosis, strategies, therapies and future directions. J Child Neurol 18:578","DOI":"10.1177\/08830738030180090401"},{"key":"CR32","doi-asserted-by":"crossref","unstructured":"Meilke PJ, Brooks DA, Hopwood J (1997) Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated-membrane protein (LAMP-1) as a diagnostic marker. Clin Chem 43:1325","DOI":"10.1093\/clinchem\/43.8.1325"},{"key":"CR33","doi-asserted-by":"crossref","unstructured":"Meilke PJ, Hopwood JJ, Clague AE, et al (1999) Prevalence of lysosomal storage diseases. JAMA 281:249","DOI":"10.1001\/jama.281.3.249"},{"key":"CR34","doi-asserted-by":"crossref","unstructured":"Moser HW, Loes DJ, Melham ER (2000) X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 31:227","DOI":"10.1055\/s-2000-9236"},{"key":"CR35","doi-asserted-by":"crossref","unstructured":"Moser HW, Raymond GV, Koehler W, et al (2003) Evaluation of the preventive effect of glyceryl trioleate-trierucate (?Lorenzo?s Oil?) therapy in x-linked adrenoleukodystrophy: results of concurrent trials. Adv Exp Med Biol 544:369","DOI":"10.1007\/978-1-4419-9072-3_47"},{"key":"CR36","unstructured":"Peters C (2004) Hematopoietic stem cell transplantation for storage diseases. In: Blume KG, Forman SJ, Applebaum FR (eds) Hematopoietic stem cell transplantation, 3rd edn. Blackwell, Oxford, pp 1455?1470"},{"key":"CR37","doi-asserted-by":"crossref","unstructured":"Peters C, Shapiro EG, Krivit W, et al (1998) Hurler: II. Outcome of HLA genotypically HLA-identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood 91:2601","DOI":"10.1182\/blood.V91.7.2601"},{"key":"CR38","doi-asserted-by":"crossref","unstructured":"Peters C, Krivit W (2000) Hematopoietic cell transplantation for MPS IIB (Hunter syndrome): an ethical commentary. Bone Marrow Transplant 25:1097","DOI":"10.1038\/sj.bmt.1702398"},{"key":"CR39","doi-asserted-by":"crossref","unstructured":"Peters C, Krivit W, et al (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982?1999. Blood 104:881?888","DOI":"10.1182\/blood-2003-10-3402"},{"key":"CR40","unstructured":"Richards K, Krivit W, Kurtzberg J, et al (2002) Correction of Krabbe disease with neonatal hematopoietic stem cell transplantation (Neurodevelopmental function and survival). In: Abstracts for the American Society for Blood and Marrow Transplantation, 22?26 February, Orlando, Florida"},{"key":"CR41","unstructured":"Rose AG, Braunlin EA, Krivit W (2001) Cardiac disease in Hurler syndrome: an autopsy study of 14 patients including evidence that bone marrow transplantation prevents coronary arterial, myocardial and valvar disease. In: Lewis BA, Halen DA, et al (eds) Advances in Coronary Artery Disease. pp 695?700"},{"key":"CR42","unstructured":"Shapiro EG, Lockman L, Krivit W (1991) Bone marrow transplantation as treatment for globoid cell leukodystrophy. In: Desnick RJ (ed) Treatment of genetic diseases. Churchill-Livingstone, New York, pp 222?238"},{"key":"CR43","doi-asserted-by":"crossref","unstructured":"Shapiro EG, Lipton ME, Krivit W (1992) White matter dysfunction and its neuropsychological correlates: a longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplantation. J Clin Exp Neuropsychol 14:610","DOI":"10.1080\/01688639208402848"},{"key":"CR44","doi-asserted-by":"crossref","unstructured":"Shapiro EG, Krivit W, Lockman L, et al (2000) Long-term effect of bone marrow transplantation for childhood-onset cerebral X-linked adrenoleukodsytrophy. Lancet 356:713?718","DOI":"10.1016\/S0140-6736(00)02629-5"},{"key":"CR45","doi-asserted-by":"crossref","unstructured":"Staba SI, Krivit W, Kurtzberg J, et al (2004) Cord blood transplantation from unrelated donors in patients with Hurler syndrome. N Engl J Med 35:1960?1969","DOI":"10.1056\/NEJMoa032613"},{"key":"CR46","unstructured":"Deleted"},{"key":"CR47","doi-asserted-by":"crossref","unstructured":"Taylor RM, Farrow BRH, Stewart GI (1992) Amelioration of clinical disease following bone marrow transplantation in fucosidase deficient dogs. Am J Med Genet 42:628","DOI":"10.1002\/ajmg.1320420439"},{"key":"CR48","doi-asserted-by":"crossref","unstructured":"Tift CI, Proia RL (2000) Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases. Glycobology 10:1249","DOI":"10.1093\/glycob\/10.12.1249"},{"key":"CR49","doi-asserted-by":"crossref","unstructured":"Turner AT, Hopwood JJ, Brooks DA (2000) Enzyme replacement therapy in mucopolysaccharidosis I. Altered distribution and targeting of ?-l-iduoinidase in immunized rats. Mol Genet Metab 69:277","DOI":"10.1006\/mgme.2000.2979"},{"key":"CR50","doi-asserted-by":"crossref","unstructured":"Van Geel BM, Bezman I, Loes DJ, et al (2001) Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 49:186","DOI":"10.1002\/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R"},{"key":"CR51","unstructured":"Vermoor J, Ehlert K, Bielacks S, et al (2002) Successful allogeneic stem cell transplantation in infantile ceramidase deficiency (Farber disease) type 2\/3. Blood 100:4577"},{"key":"CR52","unstructured":"Vinnalongan X, Sanz N, et al (1992) Hypertrophic cardiomyopathy in mucopolysaccharidosis: regression after bone marrow transplantation. Pediatr Cardiol 13:10"},{"key":"CR53","doi-asserted-by":"crossref","unstructured":"Wall DA, Grangre DK, Gaulding P, et al (1998) Bone marrow transplantation for the treatment of ?-mannosidosis. J Pediatr 133:282","DOI":"10.1016\/S0022-3476(98)70237-9"},{"key":"CR54","unstructured":"Sivakumar P, Wraith JE (1999) Bone marrow transplantation in mucopolysaccharidosis Type III A: A comparison of an early treated patient with his untreated sibling. Journal of Inherited Metabolic Disease 22:1849?1850"},{"key":"CR55","doi-asserted-by":"crossref","unstructured":"Yeager AM, Uhai KA, Coles CD (2000) Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplant 26:357","DOI":"10.1038\/sj.bmt.1702489"}],"container-title":["Springer Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-004-0166-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-004-0166-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-004-0166-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T05:49:50Z","timestamp":1585892990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-004-0166-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,25]]},"references-count":55,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["166"],"URL":"https:\/\/doi.org\/10.1007\/s00281-004-0166-2","relation":{},"ISSN":["0344-4325","1432-2196"],"issn-type":[{"value":"0344-4325","type":"print"},{"value":"1432-2196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,25]]}}}